Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
作者信息
Monaco A, Goldstein G, Barnes L
出版信息
Transplant Proc. 1987 Apr;19(2 Suppl 1):28-31.
PMID:3105137
Abstract
摘要
相似文献
1
2
Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
Transplant Proc. 1987 Apr;19(2 Suppl 1):54-7.
3
Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
Transplant Proc. 1987 Apr;19(2 Suppl 1):32-6.
4
A U.S. clinical study of Orthoclone OKT3 in renal transplantation.一项关于Orthoclone OKT3在肾移植中的美国临床研究。
Transplant Proc. 1987 Apr;19(2 Suppl 1):21-7.
5
Clinical development of Orthoclone OKT3.
Transplant Proc. 1987 Apr;19(2 Suppl 1):7-16.
6
7
Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.Orthoclone OKT3在肾移植中预防排斥反应及初始无功能诱导方面的应用。
Transplant Proc. 1990 Aug;22(4):1755-8.
8
9
10
The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.用OKT3和血浆置换法治疗类固醇抵抗性肾移植排斥反应。
Transplant Proc. 1990 Aug;22(4):1761-3.
引用本文的文献
1
Cytomegalovirus infection as a complication of OKT3 therapy in kidney transplant recipients.
Ir J Med Sci. 1992 Nov;161(11):630-2. doi: 10.1007/BF02983769.
Zotero 插件